Cite

HARVARD Citation

    Snow, T. et al. (2022). Beneficial ex vivo immunomodulatory and clinical effects of clarithromycin in COVID-19. Journal of infection and chemotherapy. 28 (7), pp. 948-954. [Online]. 
  
Back to record